Duncan C. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Duncan C. Miller has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Carolin Genehr
Core Facility Stem Cells, Max‐Delbrück‐Centrum Berlin Germany
1 shared publication- Marc Bathe-Peters
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany
1 shared publication Narasimha S. Telugu
Core Facility Stem Cells, Max‐Delbrück‐Centrum Berlin Germany
1 shared publication- Narasimha Telugu
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany
1 shared publication - Paolo Annibale
University of St Andrews
1 shared publication - Philipp Gmach
Institute of Experimental Pediatric Endocrinology, Charité—Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, D-10117 Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 8 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10405
Fluorescence Spectroscopy of Low-Level Endogenous β-Adrenergic Receptor Expression at the Plasma Membrane of Differentiating Human iPSC-Derived Cardiomyocytes
The potential of human-induced pluripotent stem cells (hiPSCs) to be differentiated into cardiomyocytes (CMs) mimicking adult CMs functional morphology, marker genes and signaling characteristics has been investigated since over a decade. The evolution of the membrane localization of CM-specific G protein-coupled receptors throughout differentiation has received, however, only limited attention to date. We employ here advanced fluorescent spectroscopy, namely linescan Fluorescence Correlation Spectroscopy (FCS), to observe how the plasma membrane abundance of the β1- and β2-adrenergic receptors (β1/2-ARs), labelled using a bright and photostable fluorescent antagonist, evolves during the long-term monolayer culture of hiPSC-derived CMs. We compare it to the kinetics of observed mRNA levels in wildtype (WT) hiPSCs and in two CRISPR/Cas9 knock-in clones. We conduct these observations against the backdrop of our recent report of cell-to-cell expression variability, as well as of the subcellular localization heterogeneity of β-ARs in adult CMs.
- 8 September 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10405
Open AccessFluorescence Spectroscopy of Low-Level Endogenous β-Adrenergic Receptor Expression at the Plasma Membrane of Differentiating Human iPSC-Derived Cardiomyocytes
The potential of human-induced pluripotent stem cells (hiPSCs) to be differentiated into cardiomyocytes (CMs) mimicking adult CMs functional morphology, marker genes and signaling characteristics has been investigated since over a decade. The evolution of the membrane localization of CM-specific G protein-coupled receptors throughout differentiation has received, however, only limited attention to date. We employ here advanced fluorescent spectroscopy, namely linescan Fluorescence Correlation Spectroscopy (FCS), to observe how the plasma membrane abundance of the β1- and β2-adrenergic receptors (β1/2-ARs), labelled using a bright and photostable fluorescent antagonist, evolves during the long-term monolayer culture of hiPSC-derived CMs. We compare it to the kinetics of observed mRNA levels in wildtype (WT) hiPSCs and in two CRISPR/Cas9 knock-in clones. We conduct these observations against the backdrop of our recent report of cell-to-cell expression variability, as well as of the subcellular localization heterogeneity of β-ARs in adult CMs.
- Open Access
- 21 September 2020
- Published by Wiley in Current Protocols in Stem Cell Biology
- Vol. 55 (1) , e125
Simple Workflow and Comparison of Media for hPSC‐Cardiomyocyte Cryopreservation and Recovery
Great progress has been made with protocols for the differentiation and functional application of hPSC‐cardiomyocytes (hPSC‐CMs) in recent years; however, the cryopreservation and recovery of hPSC‐CMs still presents challenges and few reports describe in detail the protocols and general workflow. In order to facilitate cryopreservation and recovery of hPSC‐CMs for a wide range of applications, we provide detailed information and step‐by‐step protocols. The protocols are simple and use common reagents. They are comprised of a fast dissociation, cryopreservation using standard equipment, and gentle recovery following thawing. We discuss various features of the protocols, as well as their utilization in the context of common hPSC‐CM differentiation and application workflows. Finally, we compare two proprietary and two common in‐house formulations of cryopreservation media used for hPSC‐CMs, and despite differences in their price and composition find broadly similar recovery rates and cellular function after thawing. © 2019 The Authors.Basic Protocol 1: Dissociation and cryopreservation of hPSC‐CMsBasic Protocol 2: Thawing and recovery of cryogenically frozen hPSC‐CMs
- 21 September 2020
- Published by Wiley in Current Protocols in Stem Cell Biology
- Vol. 55 (1) , e125
Open AccessSimple Workflow and Comparison of Media for hPSC‐Cardiomyocyte Cryopreservation and Recovery
Great progress has been made with protocols for the differentiation and functional application of hPSC‐cardiomyocytes (hPSC‐CMs) in recent years; however, the cryopreservation and recovery of hPSC‐CMs still presents challenges and few reports describe in detail the protocols and general workflow. In order to facilitate cryopreservation and recovery of hPSC‐CMs for a wide range of applications, we provide detailed information and step‐by‐step protocols. The protocols are simple and use common reagents. They are comprised of a fast dissociation, cryopreservation using standard equipment, and gentle recovery following thawing. We discuss various features of the protocols, as well as their utilization in the context of common hPSC‐CM differentiation and application workflows. Finally, we compare two proprietary and two common in‐house formulations of cryopreservation media used for hPSC‐CMs, and despite differences in their price and composition find broadly similar recovery rates and cellular function after thawing. © 2019 The Authors.Basic Protocol 1: Dissociation and cryopreservation of hPSC‐CMsBasic Protocol 2: Thawing and recovery of cryogenically frozen hPSC‐CMs